Whole truth: resuscitating trauma patients with whole blood

Hemorrhage remains the leading cause of death from potentially survivable injuries in both military and civilian trauma. Whole blood (WB) has repeatedly proven to be the most physiologically coherent resuscitation strategy for life-threatening hemorrhage, yet modern transfusion systems have historically prioritized inventory efficiency and component fractionation over biologic fidelity. This syllabus synthesizes contemporary military and civilian evidence for WB resuscitation, with emphasis on fresh WB (FWB) obtained through walking blood banks (WBBs) and low-titer group O WB (LTOWB), the predominant WB product currently used in civilian trauma. The historical 'back to the future' arc of transfusion practice, pathophysiology of trauma-induced blood failure, and the most current transfusion outcome data are summarized. The future of both military and civilian trauma resuscitation should adopt a layered approach to transfusion-this supports the best outcomes for trauma patients and also supports the trauma system. Precision resuscitation frameworks that assess clinical outcomes for type and timing of blood transfusion have the potential to support advanced resuscitation practices. Although the academic literature lacks publications on comparisons of LTOWB and FWB, the military is actively performing analysis to determine if there are outcome benefits for FWB and revisiting the concept for fresher (or younger) whole blood to the sickest bleeding patients-acknowledging that such an approach challenges traditional blood-banking priorities and imposes logistical constraints on blood banking and trauma systems. The balance between what is best for the patient and what is feasible in the trauma system must be taken into consideration. WB (and especially younger LTOWB and FWB) has the potential to reduce total product exposure, simplify logistics, and save lives. Future directions should include prehospital WB expansion, civilian WBB surge capability, quality metrics for blood, and pragmatic trials.